Academic Journals Database
Disseminating quality controlled scientific knowledge

Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice

ADD TO MY LIST
 
Author(s): Zhang Shuo | Liang Mifang | Gu Wen | Li Chuan | Miao Fang | Wang Xiaofang | Jin Cong | Zhang Li | Zhang Fushun | Zhang Quanfu | Jiang Lifang | Li Mengfeng | Li Dexin

Journal: Virology Journal
ISSN 1743-422X

Volume: 8;
Issue: 1;
Start page: 333;
Date: 2011;
Original page

Keywords: Dengue virus | VLP | Vaccine

ABSTRACT
Abstract Background The incidence of dengue, an infectious disease caused by dengue virus (DENV), has dramatically increased around the world in recent decades and is becoming a severe public health threat. However, there is currently no specific treatment for dengue fever, and licensed vaccine against dengue is not available. Vaccination with virus-like particles (VLPs) has shown considerable promise for many viral diseases, but the effect of DENV VLPs to induce specific immune responses has not been adequately investigated. Results By optimizing the expression plasmids, recombinant VLPs of four antigenically different DENV serotypes DENV1-4 were successfully produced in 293T cells. The vaccination effect of dengue VLPs in mice showed that monovalent VLPs of each serotype stimulated specific IgG responses and potent neutralizing antibodies against homotypic virus. Tetravalent VLPs efficiently enhanced specific IgG and neutralizing antibodies against all four serotypes of DENV. Moreover, vaccination with monovalent or tetravalent VLPs resulted in the induction of specific cytotoxic T cell responses. Conclusions Mammalian cell expressed dengue VLPs are capable to induce VLP-specific humoral and cellular immune responses in mice, and being a promising subunit vaccine candidate for prevention of dengue virus infection.
Why do you need a reservation system?      Save time & money - Smart Internet Solutions